GKOS•benzinga•
FDA Sets Decision Date For Glaukos' Keratoconus Treatment Without The Need Of Surgery
Summary
Glaukos' Epioxa NDA for keratoconus is under FDA review, with a decision expected by October 2025. Phase 3 trials support its non-invasive treatment potential.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 24, 2025 by benzinga